OTR mRNA and proteins are expressed in most breast cancer cell lines and 80–90% of breast carcinomas, including TNBC tumours [17,18,19,20,21], supporting OTR as a potential target and biomarker for breast cancer. This evidence concerns the gene OXTR and neoplasm.